Cyanotech Corporation (NASDAQ:CYAN ) Q3 2024 Results Conference Call February 9, 2024 8:00 PM ET Company Participants Matt Custer - President and CEO Felicia Ladin - CFO Matt Custer Aloha from Kona, Hawaii. Thank you all for joining us today.
The New Board Members Will Bring Industry Experience to Contribute to Company Growth WOODINVILLE, Wash. , Nov. 2, 2022 /PRNewswire/ -- Anavasi Diagnostics ('Anavasi'), an NIH/RADx medical technology company focused on the development of novel molecular diagnostic testing, recently announced the election of three new outside members to its Board of Directors, Bryan Crane, PhD, Arthur Kirsch, and...
A handful of past VBR picks are becoming net asset turnaround ideas on price weakness. Ultra-low price to tangible book value and EV to EBITDA readings are entering bargain territory.
Cyanotech Corporation (NASDAQ: CYAN) reported fourth-quarter net sales of $30.2 million in fiscal 2019 compared to $34.1 million in 2018.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.